News
Anticipated Generic Releases 2025
There are several brand name medications that will lose exclusivity in the first half of…
LSU Health New Orleans Announces Non-additive, Non-Toxic Painkiller
LSU Health New Orleans announces the discovery and clinical development of a new non-opioid therapeutic…
FDA approves First Nasal Spray for Treatment of Anaphylaxis (neffy) epinephrine nasal spray
Neffy (epinephrine 2 mg/dose) is a nasal spray which may be given to treat a…
Carlisle Medical Will Be Exhibiting at the 2024 MWCEA Conference
Carlisle Medical Will Be exhibiting at the 2024 MWCEA Conference on April 10-12, 2024, at…
Carlisle Medical Will Be Exhibiting at the SCPRIMA 2024 Annual Conference
Carlisle Medical Will Be Exhibiting at the 2024 SCPRIMA Annual Conference on March 3 –…
The Carlisle Drug Reference Guide
As we enter 2024 we would like to remind you of the Carlisle Drug Reference…
Opvee (Nalmefene) Will Be Released in the Fourth Quarter of 2023
Opvee (Nalmefene) Will Be Released in the Fourth Quarter of 2023 Opvee is indicated for…
Release of Zavzpret In Late July 2023
Release of Zavzpret In Late July 2023 Zavzpret is indicated for the acute treatment of…
The Approval of Over-the-Counter Narcan Nasal Spray
The approval of over-the counter Narcan nasal spray The U.S. Food and Drug Administration approved…
Generic Latuda (Lurasidone Hydrochloride) Is Now Available
The generic formulation of Latuda (Lurasidone Hydrochloride) has been approved by the FDA. Lurasidone Hydrochloride…
